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usefulness in guiding initial antifungal therapy was approximately
70%.
Conclusion: Alternate day determination of BG concentrations in
pts with PFN is a useful adjunct in identifying those who develop
IM, when used as part of an overall clinical and radiological evalu-
ation strategy. Pts with transient elevation of BG usually had ente-
rocolitis and thus may have low-burden fungemia of gut origin.
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Background: Anaemia is one of the most dreaded complications
among patients with malignant pathologies. Its causes can be var-
ied and whatever its severity, the impact on the quality of life of
the patient remains essential. Despite this complication in cancer
patients, limited studies have been conducted in this field and so
research data in the literature concerning anaemia are very lim-
ited. This study was therefore conducted to determine the preva-
lence and the management of anaemia amongst patients with ma-
lignant diseases.
Methods: A national survey was conducted between February 2006
and March 2007. This observational multicentric study was con-
ducted with 150 experts practicing in all the major health institu-
tions or units treating patients with solid tumours and/or malignant
haematological diseases in Cameroon. Control over one day stan-
dard of consultation for each questioned expert, 534 patients were
enrolled, including 335 (62.7%) patient with solid tumour and 199
(37.3%) patient with malignant haematological disease.
Results: The median age was 48 years (range: 11- 82 years) includ-
ing 162 men (30%) and 372 women (70%). At enrollment, the me-
dian level of haemoglobin (Hb) was 10.3 g/dl (range: 4.7-17.3 g/dl)
and 38% of patient had a level of Hb < 11 g/dl. Anaemia was found
in all the cancer localizations and whatever the stage or the ther-
apeutic status of the disease. About 3/4 of the anaemic patients
received treatment by erythropoiesis stimulating agent (ESA) and
approximately 24% of them did not receive any specific treatment
for the anaemia. The median level of Hb at the introduction of the
ESA was 9.2 g/dl.
Conclusion: Our results show an improvement in the management
of anaemia and the use of the ESA in patients with various cancers.
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Objective: Identification and susceptibility tests on strains iso-
lated from blood samples of patients hospitalized in Department
of Haematology in 2007.
Materials and Methods: From January to the end of December 2007
in Mycology Laboratory the 427 positive mycological cultures from
clinical samples of patients hospitalized in Department of Haema-
tology were identified. Fifteen (3,5%) of all specimens were the
blood positive samples. The clinical material was examined accord-
ing to the standard mycological procedures. The isolated strains
were incubated on Sabouraud medium plates with addition of gen-
tamicin and chloramphenicol (Becton Dickinson). The identifica-
tion of the isolates was performed on CHROMagar Candida medium
and automatic test of ID32 C (bioMerieux). The susceptibility tests
for antifungal agents: Amphotericin B, Itraconazole, Fluconazole,
Voriconazole, Caspofungin and Posaconazole, was done using E-
tests (AB Biodisk).
Results: From the whole number of 427 samples from Department
of Haematology, the positive blood samples were 3.5% - 15. The
